3D 내시경과 같은 첨단 이미징 도구의 개발과 최소침습 수술의 효과를 높이는 데 도움이 되는 부인과 장비의 개선이 산업 성장을 가속할 것으로 예측됩니다. 내시경 검사, 복강경 검사, 절제술, 여성 불임 수술을 포함한 수술 건수가 증가함에 따라 이 제품 수요는 증가할 것으로 예상되며, 2023년 평가액은 143억 5,000만 달러를 넘어 2032년에는 약 325억 2,000만 달러에 달할 것으로 예측됩니다.
이와 더불어, 부인과 질환의 발생률이 증가함에 따라 예측 기간 동안 시장 확대에 박차를 가할 것으로 예측됩니다. 또한, 첨단 기술의 사용 증가는 산업 확장을 촉진하여 2026-2032년 10.77%의 연평균 복합 성장률(CAGR)로 틈새 시장이 성장할 것으로 예측됩니다.
세계의 부인과 기기 시장 정의/개요
여성 생식과 관련된 외과적, 치료적, 진단적 시술에 사용되는 광범위한 의료기기 및 장비를 부인과 장비라고 합니다. 부인과 장비는 여성 건강 관리의 다양한 측면에서 사용되고 있습니다. 자궁내막증, 골반 내 염증성 질환, 자궁경부암 등의 질병을 발견하고 진단하는 데 도움을 주며, 부인과 검사에서 매우 중요합니다.
부인과 기기는 다양한 부인과 질환의 진단, 치료, 모니터링에 필수적입니다. 생식기관의 이상을 확인하고, 최소침습적 수술을 하고, 피임을 하는 데 사용됩니다. 예를 들어, 초음파 검사는 난소낭종이나 자궁근종 발견에 사용되며, 복강경 검사는 자궁내막증 치료와 자궁근종 제거에 사용됩니다.
로봇 보조 수술은 더 높은 정확도와 회복 시간 단축을 제공하며, 점점 더 널리 보급될 것으로 예측됩니다. 디지털 영상 기술은 지속적으로 발전하여 더 빠른 진단과 더 정확한 상태 평가가 가능해질 것입니다. 또한, 인공지능(AI)과 머신러닝(ML)의 통합은 개인화된 치료 제안을 제공하고 환자 결과를 개선함으로써 부인과 치료에 혁명을 일으킬 수 있는 잠재력을 가지고 있습니다.
부인과 질환의 유병률 증가와 여성 건강 문제에 대한 인식이 높아지면서 세계 부인과 기기 시장을 주도하고 있습니다. 조기 진단과 치료를 원하는 여성이 증가함에 따라 이 부문의 첨단 의료기기에 대한 수요는 지속적으로 증가하고 있습니다. 세계보건기구(WHO)에 따르면, 2024년 3월 현재 자궁경부암은 여전히 전 세계 여성에서 4번째로 흔한 암이며, 2023년에는 60만 4,000명이 새로 발병할 것으로 추정되고 있습니다. 이는 검진 및 치료 기술 개선의 필요성을 강조하고 있습니다.
최소침습적 시술 및 진단 도구의 기술적 발전은 부인과 장비의 역량을 확장하고 있습니다. 이러한 기술 혁신은 의료 서비스 제공업체에게 환자 결과 개선, 회복 시간 단축, 시술 효율성 향상을 가져옵니다. 미국 식품의약국(FDA)은 2024년 2월 신규 부인과 기기 승인 건수가 전년 대비 22% 증가했다고 보고했습니다.
여성의 고령화와 이에 따른 부인과 질환 증가가 시장 성장을 견인하고 있습니다. 평균 수명이 늘어나면서 골반장기탈출증, 요실금 등의 문제를 해결하는 기기에 대한 수요가 증가하고 있습니다. 미국 인구조사국은 2030년까지 베이비붐 세대가 모두 65세 이상이 되어 부인과적 개입이 가장 많이 필요한 인구층이 확대될 것으로 예측했습니다.
규제 장벽과 까다로운 승인 절차는 세계 부인과 기기 시장에 큰 도전이 되고 있습니다. 제조업체는 새로운 기기를 시장에 출시하기 위해 복잡하고 종종 긴 규제 경로를 거쳐야 하며, 이는 기술 혁신을 지연시키고 비용을 증가시킬 수 있습니다. 미국 식품의약국(FDA)에 따르면, 2024년 6월 현재 부인과 기기의 510(k) 승인에 소요되는 평균 일수는 177일로 전년 대비 15% 증가했습니다.
신흥국에서는 의료 및 부인과 서비스에 대한 접근성이 제한되어 있어 개발의 걸림돌로 작용하고 있습니다. 중저소득 국가의 많은 여성들은 훈련된 의료 서비스 제공업체 및 적절한 의료 인프라 부족 등 적절한 부인과 진료를 받기 위한 장벽에 직면해 있습니다. 세계보건기구(WHO)는 2024년 3월, 개발도상국 여성의 62%만이 정기적인 부인과 검진을 받을 수 있다고 보고했습니다.
일부 부인과 기기의 안전성과 효과에 대한 우려로 인해 모니터링이 강화되고 시장이 위축될 수 있다는 우려가 제기되고 있습니다. 경질 메쉬 임플란트와 같은 기기를 둘러싼 과거의 논란은 환자와 의료 서비스 제공업체의 인식을 높이고 새로운 기술의 채택률에 영향을 미쳤습니다. 2024년 2월, 미국 정부책임국은 지난 2년간 부인과 기기 관련 부작용 보고가 22% 증가했다고 보고했습니다.
The development of sophisticated imaging tools like 3D endoscopes and improvements in gynaecological equipment that help to increase the effectiveness of minimally invasive surgical techniques are anticipated to propel the growth of the industry. The demand for the product is anticipated to rise due to the rising number of surgical operations, including endoscopy, laparoscopy, ablation, and female sterilization, surpassing USD 14.35 Billion valued in 2023 to reach a valuation of around USD 32.52 Billion by 2032.
In addition to this, the rising incidence of gynaecological problems is anticipated to fuel market expansion throughout the projected period. The increasing use of cutting-edge and novel technology is also anticipated to fuel industrial expansion, thus enabling the niche market grow at a CAGR of 10.77% from 2026 to 2032.
Global Gynecological Devices Market: Definition/ Overview
A wide range of medical tools and equipment used for surgical, therapeutic, and diagnostic procedures pertaining to women's reproductive health are referred to as gynecology devices. Gynecological devices are used in many aspects of women healthcare. They are crucial in gynecological exams, aiding in the detection and diagnosis of diseases such as endometriosis, pelvic inflammatory disease, and cervical cancer.
Gynaecology devices are indispensable in the diagnosis, treatment, and monitoring of various gynaecological conditions. They are used to identify abnormalities in the reproductive organs, perform minimally invasive surgeries, and provide contraception. For instance, ultrasound is employed to detect ovarian cysts and uterine fibroids, while laparoscopy is used to treat endometriosis and remove uterine fibroids.
Robotic-assisted surgery is expected to become increasingly prevalent, offering greater precision and reducing recovery time. Digital imaging techniques will continue to improve, enabling earlier diagnosis and more accurate assessment of conditions. Moreover, the integration of artificial intelligence (AI) and machine learning (ML) has the potential to revolutionize the gynecological care by providing personalized treatment recommendations and improving patient outcomes.
The increasing prevalence of gynecological disorders and the growing awareness of female health issues are driving the global Gynecological Devices Market. As more women seek early diagnosis and treatment, the demand for advanced medical devices in this field continues to rise. According to the World Health Organization, as of March 2024, cervical cancer remains the fourth most common cancer among women globally, with an estimated 604,000 new cases in 2023. This underscores the need for improved screening and treatment technologies.
Technological advancements in minimally invasive procedures and diagnostic tools are expanding the capabilities of gynecological devices. These innovations offer improved patient outcomes, reduced recovery times, and increased procedural efficiency for healthcare providers. The U.S. Food and Drug Administration reported in February 2024 that approvals for novel gynecological devices increased by 22% compared to the previous year.
The aging female population and the subsequent increase in age-related gynecological conditions are fueling market growth. As life expectancy increases, there is a greater need for devices that address issues such as pelvic organ prolapse and urinary incontinence. The U.S. Census Bureau projects that by 2030, all baby boomers will be older than 65, expanding the demographic most likely to require gynecological interventions.
Regulatory hurdles and stringent approval processes pose significant challenges for the global Gynecological Devices Market. Manufacturers must navigate complex and often lengthy regulatory pathways to bring new devices to market, which can delay innovation and increase costs. According to the U.S. Food and Drug Administration, as of June 2024, the average time for 510(k) clearance for gynecological devices was 177 days, a 15% increase from the previous year.
Limited access to healthcare and gynecological services in developing regions hinders market growth. Many women in low- and middle-income countries face barriers to receiving proper gynecological care, including a lack of trained healthcare providers and adequate medical infrastructure. The World Health Organization reported in March 2024 that only 62% of women in developing countries have access to regular gynecological screenings.
Concerns over the safety and efficacy of certain gynecological devices have led to increased scrutiny and potential market hesitation. Past controversies surrounding devices like transvaginal mesh implants have resulted in heightened awareness among patients and healthcare providers, impacting adoption rates of new technologies. The U.S. Government Accountability Office reported in February 2024 that adverse event reports related to gynecological devices increased by 22% over the past two years.
The surgical devices are emerging as a dominating segment in the global gynecology devices market, driven by technological advancements and an increasing prevalence of gynecological disorders. According to a recent report by the World Health Organization (WHO) published in March 2024, approximately 35% of women worldwide will undergo a gynecological surgical procedure in their lifetime, underscoring the critical role of these devices in women's healthcare.
Market leaders in the gynecology devices sector continue to innovate and expand their product offerings to meet growing demand. For instance, on September 15, 2024, Medtronic, a key player in the market, announced the launch of its next-generation robotic-assisted surgical system specifically designed for gynecological procedures. This cutting-edge technology promises to enhance precision and outcomes in complex surgeries, further solidifying the position of surgical devices segment at the forefront of the Global Gynecology Devices Market.
The hospitals & clinics segment is estimated to dominate the global Gynecological Devices Market growth during the forecast period. The rising need for gynaecological procedures and the use of cutting-edge technologies in clinics and hospitals are the primary causes of the high share. For instance, on January 2022, The Women's Hospital at Jackson Memorial, HCA Florida Healthcare's Kendall Regional Medical Center, and AdventHealth Celebration began utilizing Memic Innovative Surgery's Hominis Surgical System, a robotic surgical device, for gynaecological procedure.
The needs of women healthcare have grown as their lives have changed. With women becoming more conscious of their health and wellbeing, there has been a growing need for improved gynecological therapies. Acknowledging this potential, global medical device manufacturers have developed innovative gynecology gadgets that are painless and effective, enabling patients to heal quickly.
North America Region?
The North America is emerging as the dominating region in the global Gynecological Devices Market. Due to the rising incidence of cancer linked to gynecology, the prominence of device makers, and improvements in technology, the North American area currently owns the greatest proportion of the global market for gynecological devices. An expected 65,950 new instances of uterine corpus cancer were detected in the US in 2022, according to the American Cancer Society. Cervical cancer is the most concerning of all the cancers, and its incidence in American women is rising quickly. In the US, 14,100 cases of cervical cancer are anticipated in 2022.
In addition to this, an update from the Canadian Cancer Society in 2022 projects that 8,100 Canadian women would likely receive a uterine cancer diagnosis in 2022. As a result, the need for gynecological equipment in the nation is increasing due to the increased prevalence of cancer. Moreover, the nationwide presence of rivals, mergers, and acquisitions pertaining to gynaecological devices accelerates market expansion. For instance, in October 2021, Hologic, Inc., signed a final agreement to purchase Bolder Surgical, for about USD 160 million, subject to working capital and other customary closing adjustments.
The Asia-Pacific (APAC) region is estimated to grow at a highest CAGR during the forecast period, driven by increasing awareness of women's health issues, improving healthcare infrastructure, and rising disposable incomes. According to a recent report by the World Health Organization (WHO) published on March 15, 2024, the prevalence of gynecological disorders in the APAC region has increased by 12% over the past five years, highlighting the urgent need for advanced medical devices.
Key players in the gynecology devices market are actively pursuing opportunities in the APAC region through strategic partnerships and product launches. For instance, on September 12, 2023, Medtronic, a leading medical technology company, announced the establishment of a new research and development center in Singapore, focusing on innovative gynecological devices tailored to the specific needs of Asian women.
The global Gynecological Devices Market is a dynamic and competitive landscape, with a mix of established players and emerging challengers vying for market share. These players are actively working to strengthen their presence by implementing strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are dedicated to continuously improving their product line to meet the needs of a wide range of customers in different regions.
Some of the key players operating in the global Gynecological Devices Market include:
Medtronic plc, Cooper Surgical, Inc., Richard Wolf GmbH, Hologic, Inc., Boston Scientific Corp., Stryker Corp., Karl Storz GmbH & Co. KG, Ethicon, Inc. (Johnson & Johnson MedTech), Cook Medical, Bayer AG, Gynemed, Gynex Corp.
In September 2022, The Guardenia Contained Extraction System was introduced by Olympus, a leading worldwide technology company that designs and provides cutting-edge solutions for medical and surgical procedures.
In June 2022, the new Hystero-V, a single-use hysteroscope was introduced by UroViu Corp. With its hydrophilic covering, the 12-Fr semi-rigid Hystero-V allows for a smooth insertion and enhanced visualization for incredibly successful intrauterine exams.
On July 2021, the Hugo Robotic-Assisted Surgery (RAS) system, developed by Medtronic Plc, was utilized to execute the first gynaecological treatment in Panama.